private digital health companies obesity management glp-1 Dr. Craig Primack talks Hims & Hers launching its own offering as demand rises Nutritional and lifestyle supportive care

Regular lab rechecks track your progress, and the Asymmetric Health team adjusts dosages, swaps therapies, or adds new protocols as your biology responds

Clinical trials have shown significant average weight loss with medications such as semaglutide and tirzepatide, but individual results are not guaranteed

March 28, 2023

Due to widespread knowledge of their weight loss properties, Ozempic and other GLP-1 agonists are increasingly being prescribed to people who use them for weight loss rather than treating type 2 diabetes (Cohen, 2024)

On October 8, the Congressional Budget Office (CBO) released a report on the potential federal cost if Medicare decides to cover anti-obesity medications (AOMs) for weight loss, including the much-discussed class of glucagon-like peptide 1s (GLP-1s)

If youve been injured by a GLP-1 medication, you should expect these arguments: Preemption: Manufacturers argue that FDA-approved labeling shields them from liability